Clinically-Relevant ABC Transporter for Anti-Cancer Drug Resistance

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Multiple drug resistance (MDR) significantly reduces chemotherapy effectiveness in cancer treatment.
• Overexpression of ATP binding cassette (ABC) transporters is a primary mechanism driving MDR by exporting drugs from cancer cells.

Purpose of the Study:

• To review recent advancements in understanding cancer-related ABC transporters.
• To explore the physiological functions and structures of key ABC transporters.
• To highlight the development of novel ABC transporter inhibitors for combination therapy.

Main Methods:

• Literature review of recent scientific publications.
• Analysis of the roles of ABC transporters in cancer drug resistance.
• Summary of emerging ABC transporter inhibitor compounds.

Main Results:

• ABC transporters are crucial in mediating MDR by facilitating drug efflux.
• Understanding ABC transporter structure and function is key to developing effective inhibitors.
• Inhibitors of ABC transporters show potential for enhancing standard chemotherapy.

Conclusions:

• Modulating ABC transporter activity is a viable strategy to overcome MDR.
• Combination therapy with ABC transporter inhibitors and chemotherapeutics may improve patient outcomes.
• Further research into novel ABC transporter inhibitors is warranted.